Shares of Youngevity International Inc (NASDAQ:YGYI) have been assigned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.
Analysts have set a 12 month consensus price target of $6.00 for the company, according to Zacks. Zacks has also given Youngevity International an industry rank of 93 out of 255 based on the ratings given to related companies.
An institutional investor recently bought a new position in Youngevity International stock. Millennium Management LLC acquired a new stake in Youngevity International Inc (NASDAQ:YGYI) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 21,093 shares of the company’s stock, valued at approximately $94,000. Millennium Management LLC owned 0.07% of Youngevity International at the end of the most recent quarter. 6.89% of the stock is currently owned by institutional investors and hedge funds.
Youngevity International Company Profile
Youngevity International, Inc develops and distributes health and nutrition related products and services through independent direct selling network in the United States and internationally. It operates in two segments, Direct Selling and Commercial Coffee. The company offers approximately 5,500 products, including nutritional, vitamin, mineral, herbal, liquid, and dietary supplements; apparel; fashion and jewelry accessories; digital products; and packaged foods.
Featured Article: Initial Coin Offering (ICO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Youngevity International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Youngevity International and related companies with MarketBeat.com's FREE daily email newsletter.